Maxcyte (MXCT) Interest Expenses (2020 - 2022)

Maxcyte (MXCT) has reported Interest Expenses for 3 consecutive years, with $11000.0 the latest figure, recorded in Q4 2022.

• On a quarterly basis, Interest Expenses changed N/A year-over-year to $11000.0 in Q4 2022; TTM through Dec 2022 was $416000.0, a 60.17% decrease from a year earlier, with the FY2022 full-year figure at $127000.0, down 87.84% from the prior year.
• Interest Expenses was $11000.0 for Q4 2022 at Maxcyte, down from $116000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $742300.0 in Q1 2021 and troughed at $11000.0 in Q4 2022.
• A 3-year average of $235000.0 and a median of $213950.0 in 2020 frame the typical range for Interest Expenses.
• The widest YoY moves for Interest Expenses: up 9.8% in 2021, down 91.99% in 2021.
• Over 3 years, Interest Expenses stood at $280600.0 in 2020, then advanced by 2.99% to $289000.0 in 2021, then slumped by 96.19% to $11000.0 in 2022.
• The last three Interest Expenses figures came in at $11000.0 (Q4 2022), $116000.0 (Q3 2022), and $289000.0 (Q3 2021), per Business Quant data.